| Name | Landogrozumab |
|---|
| Description | Landogrozumab (LY2495655) is an humanized anti-myostatin monoclonal antibody. Landogrozumab effectively improves muscle volume, hand grip strength and function. Landogrozumab can be used for the research of muscle wasting disease[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Landogrozumab (3 和 15 mg/kg;静脉注射 1 次) 影响杜氏肌营养不良老年小鼠的肌肉质量[1]。 Animal Model: Duchenne muscular dystrophy (DMD) C57BL/10-mdx mouse model[1] Dosage: 3 and 50 mg/kg Administration: Intravenous injection; 3 and 50 mg/kg once Result: Increasesd muscle mass of aged mice at a dose of 50 mg/kg while 3 mg/kg showed no significant effects. |
| References |
| No Any Chemical & Physical Properties |